Cargando…
Comparative genomic mapping of the bovine Fragile Histidine Triad (FHIT) tumour suppressor gene: characterization of a 2 Mb BAC contig covering the locus, complete annotation of the gene, analysis of cDNA and of physiological expression profiles
BACKGROUND: The Fragile Histidine Triad gene (FHIT) is an oncosuppressor implicated in many human cancers, including vesical tumors. FHIT is frequently hit by deletions caused by fragility at FRA3B, the most active of human common fragile sites, where FHIT lays. Vesical tumors affect also cattle, in...
Autores principales: | Uboldi, Cristina, Guidi, Elena, Roperto, Sante, Russo, Valeria, Roperto, Franco, Di Meo, Giulia Pia, Iannuzzi, Leopoldo, Floriot, Sandrine, Boussaha, Mekki, Eggen, André, Ferretti, Luca |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1513570/ https://www.ncbi.nlm.nih.gov/pubmed/16719907 http://dx.doi.org/10.1186/1471-2164-7-123 |
Ejemplares similares
-
Molecular and epigenetic analysis of the fragile histidine triad tumour suppressor gene in equine sarcoids
por: Strazzullo, Maria, et al.
Publicado: (2012) -
The Clinical Relevance of Fragile Histidine Triad Protein (FHIT) in Patients with Bladder Cancer
por: Liu, Xiao-Ping, et al.
Publicado: (2018) -
Evaluation of Relationship between Occurrence of Liver Cancer and Methylation of Fragile Histidine Triad (FHIT) and P16 Genes
por: Bai, Yu, et al.
Publicado: (2019) -
Germinal epimutation of Fragile Histidine Triad (FHIT) gene is associated with progression to acute and chronic adult T-cell leukemia diseases
por: Bellon, Marcia, et al.
Publicado: (2021) -
Loss of fragile histidine triad (Fhit) protein expression alters the translation of cancer-associated mRNAs
por: Kiss, Daniel L., et al.
Publicado: (2018)